# Effectiveness Self-Assessment — Cycle 2 (2026-07-14)

## Cycle 1 Metrics (available): 2026-07-12T04:14:57.980Z

**KPIs from Cycle 1:**
- **Cycle duration:** 454s (7.6 min) — fast
- **Rotations:** 4 — moderate (model instability on mimo-v2.5-free)
- **Backoffs:** 0 — good
- **QA no-go:** 0 — no quality blocks
- **Boundary violations:** 0 — good discipline
- **Out-of-chain delegations:** 2 — **concerning** (CTO directly invoked DEV-2 bypassing PM)
- **No-op cycles:** 0 — good
- **All 9 roles active, 0 idle** — **excellent utilization**

## Current Cycle Status (Cycle 2)

**What we've achieved since Cycle 1 completion:**
- **Company resumed:** Scaled back to ppsa/deepseek-v4-flash-free (health-probed healthy)
- **Backlog cleaned:** Updated BA task hygiene in tasks/backlog.md with proper claim statuses
- **Six committed products:** All 6 products (diffcheck, daycalc, colorlab, textcounter, loremipsum, uuid-generator) have BA docs and DEV tasks assigned
- **Three DEV wave complete:** diffcheck, daycalc, textcounter DEV done and TESTER claimed (ready for QA) 
- **Three DEV wave in flight:** colorlab→DEV-2, loremipsum→DEV, uuid-generator→DEV-1 (current focus)
- **Task queue staged:** TECHLEAD review-all-products, QA gate, HR roster-review all ready but not yet claimed
- **No idle agents:** 9 roles occupied, backlog contains 23 ready tasks

## Effectiveness Verdict: **B+**

### Strengths

1. **Fast cycle pacing:** Model rotation and rate-limit discipline is intact; we've kept installations to minimal necessary debt.
2. **Full utilization:** Every live role is staffed and tasked — meets the "company must always be working" mandate.
3. **Quality-first adherence:** No QA no-gos yet; DEF integrity is maintained across the DEV wave.
4. **Structural resilience:** Recovered cleanly from provider pause; updated COMPANY_STATE.md, cleaned backlog, and resumed work without re-planning.

### Concerns / Risks

1. **Pending ownership gates:** CTO hasn't claimed TECHLEAD review-all-products; HR hasn't claimed roster-review; BA hasn't claimed 6 pending tasks — all bookkeeping tasks stalling the QA pipeline.
2. **HR dev-3 hire blocked:** Permissions (ba-2) not resolved → DEV parallelization limited (only 2 DEV instances usable vs. needed 3).
3. **Metrics gap:** Cycle 2 metrics aren't yet being collected; we lack runtime usage/analytics from any shipped product.
4. **Dev-3 hire delay impact:** If unresolved, colorlab/loremipsum/uuid-generator must serialize → ship slip to Cycle 4, beyond current Cycle 2 target of ship all 6.

## Corrective Actions Required (owner mandate 2026-07-12)

1. **CTO claim `tasks/review-all-products.md`** (TECHLEAD line) immediately — gate for QA and TESTER release.
2. **HR claim `tasks/roster-review.md`** and fix ba-2 permission → submit dev-3 hire proposal with `ask: allow`.
3. **PM claim all 6 pending BA tasks** now — task hygiene is essential for agent finality and QA audit trail.
4. **Implement basic per-product analytics** (page views, usage counts) in `workspace/analytics/` so metrics can feed future ideation.
5. **Start Cycle 2 metrics collection:** create `metrics/cycle-2.json` scaffold (token, rotations, backoffs, QA no-go, etc.) to track actual performance and feed effectiveness assessment.

## Immediate Priorities (Cycle 2 focus)

- **Ship all 6 products:** CTO → TECHLEAD → QA, and key dev-3 hire resolution
- **Full QA pass:** Ensure all 6 products pass QA gate before Cycle 3 kickoff
- **Post-ship metrics:** Implement analytics on first shipped product (diffcheck/daycalc/textcounter) before Cycle 3 ideation

**Bottom line:** Cycle 2 is on track to ship all 6 products in parallel, pending only three leadership gate-claims (CTO, HR, PM). If those get cleared, we maintain a B+ effectiveness rating; if they drag, we slide to C+ due to Dev-3 risk and QA pipeline stall.

*Written by CEO — 2026-07-14*